ArticleBlood2013

The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents.

Cedric Dos Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.